How many institutions held STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share in Q1 2023?

114 institutional investors reported STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share for Q1 2023. Use the holders table for investor-level position and value details.

Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO)

Q: What does CUSIP 869367102 represent in this 13F holders report?

CUSIP 869367102 is the security identifier for STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 869367102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 16,182,923
Total 13F shares: 53,720,779
Share change: +3,695,720
Total reported value: $247,499,715
Put/Call ratio: 220%
Price per share: $4.62
Number of holders: 114
Value change: +$10,470,599
Number of buys: 68
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 869367102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	34%	5,565,099	$44,966,000	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	30%	4,860,140	$39,269,932	—	31 Dec 2022	13F
BVF INC/IL	13F	Company	21%	3,347,946	$27,051,404	—	31 Dec 2022	13F
Rubric Capital Management LP	13F	Company	20%	3,211,872	$25,951,926	—	31 Dec 2022	13F
FRANKLIN RESOURCES INC	13F	Company	18%	2,838,135	$22,932,130	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	16%	2,644,672	$21,368,950	—	31 Dec 2022	13F
Holocene Advisors, LP	13F	Company	14%	2,313,542	$18,693,419	—	31 Dec 2022	13F
BAILLIE GIFFORD & CO	13F	Company	12%	1,868,615	$15,098,409	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	11%	1,851,285	$14,958,383	—	31 Dec 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	11%	1,776,479	$14,353,950	—	31 Dec 2022	13F
Samsara BioCapital, LLC	13F	Company	10%	1,675,579	$13,538,678	—	31 Dec 2022	13F
Verition Fund Management LLC	13F	Company	9.9%	1,604,229	$12,962,170	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	8.5%	1,369,021	$11,062,000	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	6.7%	1,077,468	$8,705,941	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	6.3%	1,021,079	$8,250,000	—	31 Dec 2022	13F
Parkman Healthcare Partners LLC	13F	Company	5.4%	865,975	$6,997,078	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	4.9%	790,600	$6,388,048	—	31 Dec 2022	13F
S.c.a. Candriam	13F	Individual	4.9%	789,184	$6,376,308	—	31 Dec 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	4.1%	667,476	$5,393,207	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.1%	667,543	$5,392,000	—	31 Dec 2022	13F
FMR LLC	13F	Company	3.9%	624,334	$5,044,619	—	31 Dec 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	3.5%	561,828	$4,538,000	—	31 Dec 2022	13F
MARSHALL WACE, LLP	13F	Company	3.5%	559,915	$4,524,113	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	2.8%	460,563	$3,721,349	—	31 Dec 2022	13F
Kynam Capital Management, LP	13F	Company	2.5%	404,544	$3,268,716	—	31 Dec 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	2.4%	383,100	$3,095,448	—	31 Dec 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	1.9%	312,981	$2,528,886	—	31 Dec 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	1.8%	283,800	$2,293,104	—	31 Dec 2022	13F
Endurant Capital Management LP	13F	Company	1.7%	281,895	$2,277,712	—	31 Dec 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	1.7%	275,591	$2,226,775	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	1.5%	238,705	$1,928,736	—	31 Dec 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.5%	237,895	$1,922,192	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	1.4%	227,927	$1,841,650	—	31 Dec 2022	13F
Pentwater Capital Management LP	13F	Company	1.4%	225,000	$1,818,000	—	31 Dec 2022	13F
Man Group plc	13F	Company	1.3%	216,444	$1,748,868	—	31 Dec 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.3%	208,130	$1,682,000	—	31 Dec 2022	13F
NORGES BANK	13F	Company	1.3%	206,200	$1,666,096	—	31 Dec 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.2%	198,106	$1,600,696	—	31 Dec 2022	13F
JPMORGAN CHASE & CO	13F	Company	1.2%	187,778	$1,517,000	—	31 Dec 2022	13F
Trexquant Investment LP	13F	Company	0.95%	154,206	$1,245,984	—	31 Dec 2022	13F
Tekla Capital Management LLC	13F	Company	0.91%	147,531	$1,192,050	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.9%	145,590	$1,176,367	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.89%	144,147	$1,164,708	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.74%	120,002	$969,616	—	31 Dec 2022	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.72%	115,981	$937,126	—	31 Dec 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.69%	110,900	$896,072	—	31 Dec 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.67%	108,963	$880,419	—	31 Dec 2022	13F
XTX Topco Ltd	13F	Company	0.63%	101,369	$819,062	—	31 Dec 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.61%	98,637	$796,987	—	31 Dec 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.53%	85,390	$689,951	—	31 Dec 2022	13F

Institutional Holders of Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) as of Q1 2023

As of 31 Mar 2023, Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,720,779 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Rubric Capital Management LP, BVF INC/IL, STATE STREET CORP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Holocene Advisors, LP, BAILLIE GIFFORD & CO, and Candriam S.C.A.. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

116

Q1 2023 holders

114

Holder diff

-2

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.